In April 2007, Charles Scheeler got a call from Matthew Parrella. Scheeler is a partner in DLA Piper’s Baltimore office. He had spent the previous year working with DLA chairman and former Senate majority leader George Mitchell on his investigation into performance-enhancing drugs in Major League Baseball. Parrella is a prosecutor in the Northern District of California and one of the leaders of the government’s own steroid investigation.
Parrella and Scheeler had been in touch for the past year, each following similar but separate tracks. Now their paths would merge. The government had been talking to a person who had spent years selling steroids to major leaguers, Parrella told Scheeler. That person had entered into a plea agreement with the U.S. Department of Justice. The agreement required him to cooperate fully with DLA’s investigation, a violation of long-standing Department of Justice policy that barred prosecutors from publicly identifying offenders they did not intend to charge.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
